A Long-term Observational Study in Participants Who Have Received PBGENE-HBV
Заболявания:
Chronic HBV Infection
Спонсор: Precision BioSciences, Inc.
Налично на:
БГ
Обобщение
Participants who received at least one dose of PBGENE-HBV will be enrolled in this LTFU study.
Описание
This is a LTFU observational study designed to evaluate the safety of PBGENE-HBV in participants previously exposed to PBGENE-HBV. This study protocol does not include administration of PBGENE-HBV.
Кой може да участва
Inclusion Criteria:
1. Participant has received at least 1 dose of PBGENE-HBV investigational product in a prior clinical study
2. Participant, or their legally authorized representative, has provided signed informed consent.
Exclusion Criteria:
* N/A
БГ
EN